Emerald Mutual Fund Advisers Trust’s Transmedics TMDX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.1M	Buy	302,074 +72,748	+32%	+$6.16M	0.71%	63
2026 Q1	$22.8M	Sell	229,326 -575	-0.3%	-$75K	1.11%	25
2025 Q4	$28M	Sell	229,901 -8,537	-4%	-$1.07M	1.36%	17
2025 Q3	$26.8M	Sell	238,438 -17,205	-7%	-$2.01M	1.38%	17
2025 Q2	$34.3M	Sell	255,643 -6,928	-3%	-$761K	2.09%	5
2025 Q1	$17.7M	Buy	262,571 +43,296	+20%	+$2.98M	1.25%	27
2024 Q4	$13.7M	Buy	219,275 +94,034	+75%	+$8.75M	0.83%	47
2024 Q3	$19.7M	Sell	125,241 -123,816	-50%	-$19.1M	1.02%	34
2024 Q2	$37.5M	Sell	249,057 -165,457	-40%	-$19.8M	1.97%	5
2024 Q1	$30.6M	Buy	414,514 +425	+0.1%	+$35K	1.6%	10
2023 Q4	$32.7M	Buy	414,089 +57,342	+16%	+$3.46M	1.73%	10
2023 Q3	$19.5M	Buy	356,747 +2,285	+0.6%	+$164K	1.18%	21
2023 Q2	$29.8M	Buy	354,462 +1,089	+0.3%	+$83.4K	1.61%	7
2023 Q1	$26.8M	Sell	353,373 -88,418	-20%	-$6.11M	1.58%	8
2022 Q4	$27.3M	Buy	441,791 +57,344	+15%	+$3.05M	1.69%	6
2022 Q3	$16M	Buy	384,447 +37,098	+11%	+$1.61M	1.01%	37
2022 Q2	$10.9M	Buy	347,349 +74,944	+28%	+$2M	0.63%	62
2022 Q1	$7.34M	Sell	272,405 -28,087	-9%	-$503K	0.32%	101
2021 Q4	$5.76M	Sell	300,492 -40,000	-12%	-$1M	0.2%	120
2021 Q3	$11.3M	Sell	340,492 -28,767	-8%	-$879K	0.39%	86
2021 Q2	$12.3M	Sell	369,259 -231,380	-39%	-$6.41M	0.4%	94
2021 Q1	$24.9M	Buy	600,639 +18,125	+3%	+$558K	0.83%	46
2020 Q4	$11.6M	Sell	582,514 -25,423	-4%	-$376K	0.4%	98
2020 Q3	$8.38M	Hold	607,937	–	–	0.37%	84
2020 Q2	$10.9M	Buy	607,937 +183,465	+43%	+$2.87M	0.51%	68
2020 Q1	$5.13M	Sell	424,472 -5,396	-1%	-$90.4K	0.32%	99
2019 Q4	$8.17M	Buy	429,868 +233,358	+119%	+$4.29M	0.33%	104
2019 Q3	$4.67M	Hold	196,510	–	–	0.21%	135
2019 Q2	$5.7M	Buy	+196,510	New	+$5.36M	0.23%	129

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TMDX Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust increased its Transmedics (TMDX) stake by 32% in Q2 2026, buying an estimated $6.16M and bringing the position to 302,074 shares worth $20.1M. The position accounts for 0.71% of the portfolio, ranked #63.

Emerald Mutual Fund Advisers Trust first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $37.5M in Q2 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Emerald Mutual Fund Advisers Trust held 302,074 shares of Transmedics worth $20.1M as of Q2 2026.
Emerald Mutual Fund Advisers Trust bought 72,748 Transmedics shares in Q2 2026, an estimated $6.16M.
Transmedics made up 0.71% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #63 holding.
Emerald Mutual Fund Advisers Trust first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
Emerald Mutual Fund Advisers Trust's Transmedics position peaked at $37.5M in Q2 2024.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.